Naofumi Kagara Selected Research

Naofumi Kagara Research Topics

Disease

42	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2004
34	Neoplasms (Cancer) 01/2022 - 05/2007
17	Neoplasm Metastasis (Metastasis) 05/2021 - 05/2007
5	Stomach Neoplasms (Stomach Cancer) 11/2012 - 11/2010
3	Lymphatic Metastasis 01/2016 - 11/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2016 - 01/2013
1	Necrosis 01/2022
1	Osteomyelitis 01/2022
1	Margins of Excision 01/2022
1	Intraductal Papilloma 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Phyllodes Tumor (Cystosarcoma Phylloides) 03/2016
1	Fibroadenoma 03/2016
1	Neoplasm Micrometastasis 01/2016
1	Ductal Carcinoma 01/2013
1	Thrombosis (Thrombus) 11/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011
1	Chylous Ascites 11/2011
1	Carcinoma (Carcinomatosis) 11/2011
1	Papillary Adenocarcinoma 11/2011
1	Stomatitis 06/2011

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 07/2013
10	Messenger RNA (mRNA)IBA 12/2019 - 05/2007
7	Estrogen ReceptorsIBA 03/2020 - 01/2013
6	Circulating Tumor DNAIBA 10/2019 - 01/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2021 - 11/2012
5	Phenobarbital (Luminal)FDA Link 02/2021 - 10/2014
5	Nucleic AcidsIBA 12/2019 - 10/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021 - 11/2012
4	Epirubicin (Ellence)FDA LinkGeneric 02/2021 - 11/2012
4	ParaffinIBA 01/2021 - 06/2014
4	Formaldehyde (Formol)FDA Link 01/2021 - 06/2014
3	Hormones (Hormone)IBA 01/2022 - 07/2013
3	Fluorouracil (Carac)FDA LinkGeneric 02/2021 - 04/2015
3	Tumor Biomarkers (Tumor Markers)IBA 08/2020 - 01/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2019 - 01/2013
2	AutoantibodiesIBA 01/2021 - 01/2016
2	Cell-Free Nucleic AcidsIBA 03/2020 - 01/2018
2	SonazoidIBA 10/2019 - 08/2017
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 11/2017
2	Tamoxifen FDA LinkGeneric 08/2018 - 12/2017
2	hydrogen sulfite (bisulfite)IBA 02/2018 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 05/2004
2	Carcinoembryonic AntigenIBA 01/2017 - 10/2016
2	Docetaxel (Taxotere)FDA Link 11/2014 - 06/2011
2	A-Form DNA (A-DNA)IBA 10/2014 - 01/2014
2	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2014 - 12/2013
2	Therapeutic UsesIBA 11/2012 - 11/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2011 - 11/2011
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	exemestane (Aromasin)FDA Link 01/2022
1	Acrolein (Aqualin)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2021
1	PlatinumIBA 02/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	LigandsIBA 03/2020
1	Aromatase InhibitorsIBA 03/2020
1	Coloring Agents (Dyes)IBA 10/2019
1	Keratins (Keratin)IBA 07/2019
1	VimentinIBA 07/2019
1	Androgen Receptors (Androgen Receptor)IBA 04/2019
1	Periodic AcidIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 08/2018
1	Keratin-19 (Keratin 19)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 12/2017
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2017
1	Aspartic Acid (Aspartate)FDA Link 12/2017
1	Contrast MediaIBA 08/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	AntigensIBA 10/2016
1	Insulin-Like PeptidesIBA 03/2016
1	ImmunosorbentsIBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	EnzymesIBA 01/2016
1	ral Guanine Nucleotide Exchange FactorIBA 07/2014
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 07/2014
1	Glutathione S-Transferase piIBA 07/2014
1	RNA (Ribonucleic Acid)IBA 06/2014
1	Dihydrotachysterol (AT 10)IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2013

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 02/2021 - 11/2010
11	Neoadjuvant Therapy 02/2021 - 11/2011
7	Therapeutics 12/2019 - 11/2010
6	Radiotherapy 11/2014 - 11/2010
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 10/2014
3	Segmental Mastectomy (Lumpectomy) 01/2022 - 11/2011
2	Mastectomy (Mammectomy) 01/2022 - 01/2022
2	Adjuvant Chemotherapy 11/2011 - 11/2010
2	Gastrectomy 11/2011 - 11/2011
2	Chemoradiotherapy 11/2010 - 11/2010
1	Debridement 01/2022
1	Pancreaticoduodenectomy 11/2011
1	Laparoscopic Cholecystectomy 11/2011
1	Pancreatectomy 11/2011
1	Cholecystectomy 11/2011